208 related articles for article (PubMed ID: 31370893)
1. Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma.
Sun K; Li W; Han J; Wu H
BMC Cancer; 2019 Aug; 19(1):761. PubMed ID: 31370893
[TBL] [Abstract][Full Text] [Related]
2. Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis.
McDowell BD; Chapman CG; Smith BJ; Button AM; Chrischilles EA; Mezhir JJ
Ann Surg; 2015 Apr; 261(4):740-5. PubMed ID: 24979599
[TBL] [Abstract][Full Text] [Related]
3. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
4. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
[TBL] [Abstract][Full Text] [Related]
5. Hepatectomy is associated with survival in intrahepatic cholangiocarcinoma: An observational study by instrumental variable analysis.
Chen W; Wu Z; Cao L
Medicine (Baltimore); 2021 Mar; 100(9):e24147. PubMed ID: 33655908
[TBL] [Abstract][Full Text] [Related]
6. Early-onset pancreatic cancer: a population-based study using the SEER registry.
Ansari D; Althini C; Ohlsson H; Andersson R
Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
[TBL] [Abstract][Full Text] [Related]
7. The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER database.
Hu H; Xu Y; Zhang Q; Gao Y; Wu Z
Expert Rev Anticancer Ther; 2024 Jun; 24(6):467-476. PubMed ID: 38656796
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
9. Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER-based analysis of 15,836 cases.
Fu N; Jiang Y; Weng Y; Chen H; Deng X; Shen B
Cancer Med; 2021 Sep; 10(17):5948-5963. PubMed ID: 34288562
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
Chen X; Liu G; Wang K; Chen G; Sun J
Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
[TBL] [Abstract][Full Text] [Related]
11. Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Population-Based Surveillance, Epidemiology and End Results (SEER) Analysis.
Wang L; Yang L; Chen L; Chen Z
Med Sci Monit; 2019 Nov; 25():8230-8241. PubMed ID: 31677259
[TBL] [Abstract][Full Text] [Related]
12. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
Luo Y
Clin Transl Oncol; 2022 Jan; 24(1):76-83. PubMed ID: 34219204
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes for anaplastic pancreatic cancer: a population-based study.
Clark CJ; Graham RP; Arun JS; Harmsen WS; Reid-Lombardo KM
J Am Coll Surg; 2012 Nov; 215(5):627-34. PubMed ID: 23084492
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
[TBL] [Abstract][Full Text] [Related]
15. The role of radiotherapy in patients with resected ampullary carcinoma: findings based on the SEER database.
Zhao W; Wang B; Zhao A; Tian Q; Zhang L; Wang L; Zhao X; Yang J; Dong D
HPB (Oxford); 2019 Nov; 21(11):1535-1540. PubMed ID: 31056288
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation
Li W; Xiao H; Wu H; Xu X; Zhang Y
Front Oncol; 2021; 11():592835. PubMed ID: 34123771
[TBL] [Abstract][Full Text] [Related]
19. Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis.
Yao YC; Chen JQ; Yin L; Lin WH; Peng JH; Fan WH
BMC Gastroenterol; 2022 Mar; 22(1):114. PubMed ID: 35264117
[TBL] [Abstract][Full Text] [Related]
20. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
